Menu visibility control

Video

Events

Startup Surgery

Most Recent

Crowdfunding

PropTech firm No Agent raises over £500,000 through crowdfunding

News

Oxford’s AI firm Oxbotica gets £8.6m to lead driverless car consortium

Tech City Voices

Five reasons why starting a tech business is a marathon, not a sprint

Press Releases

Redbox Digital Gains Prestigious Magento Global Elite Partner Status
More than £1m transacted using Loot in its first 4 months
HT2 Labs receives Series A investment from City & Guilds Group

London-based biotech company Pulmocide raises $30.4m Series B

biotech
twitterlinkedinFacebookgoogle_plustwitterlinkedinFacebookgoogle_plus

Pulmocide, a biotech firm run by former GlaxoSmithKline scientists, has closed a $30.4m Series B.

The funding, which will be used to further develop its wholly-owned treatments for respiratory syncytial virus (RSV) and pulmonary aspergillosis, came from SV Life Sciences, Johnson & Johnson’s venture capital arm.

The London-based company also drew support from Touchstone Innovations and F-prime, the venture capital arm of Fidelity.

Wales-based biotech company Creo Medical Group floats on AIM

“Respiratory infections are a significant cause of global morbidity and mortality with a high unmet medical need,” said company CEO Garth Rapeport.

“Pulmocide is developing bespoke inhaled medicines to provide effective and safe therapies for the treatment of RSV and pulmonary Aspergillosis. Our approach is to direct the drug to the site of the infection through an inhaler,” he explained.

The funding, the CEO added, will enable the firm to advance two of its ‘novel’ compounds through early clinical development.

“We are delighted by the interest we’ve received in this round and would like to thank our new and existing shareholders for their support and continued commitment to Pulmocide. We look forward to providing further pipeline updates as developments progress with our important programmes,” Rapeport added.

The news comes after the biotech firm secured $17m Series A round from four investors in November 2013.

Enter your email address to receive updates straight to your inbox

* indicates required
Send me news on...
twitterlinkedinFacebookgoogle_plustwitterlinkedinFacebookgoogle_plus

Editor's picks

team-no agent

PropTech firm No Agent raises over £500,000 through crowdfunding
posted 6 hours ago

self-driving cars

Oxford’s AI firm Oxbotica gets £8.6m to lead driverless car consortium
posted 7 hours ago

london marathon

Five reasons why starting a tech business is a marathon, not a sprint
posted 8 hours ago

chickens

Farmdrop gets £7m from investors including Skype co-founder Niklas Zennström
posted 12 hours ago

gender pay reporting

Making gender pay gap reporting work for tech
posted on April 23, 2017

tech stats

Top tech stats: UK FinTech, Brexit, cybersecurity and more
posted on April 22, 2017